Long COVID-19 has played a part in killing 3,544 people in the US, according to a government study that suggests how severe SARS-CoV-2’s impact may remain after the pandemic era passes.
Deaths from the syndrome peaked in February and were more common among men than women, according to an analysis of death certificates as of October 7 conducted by the Centers for Disease Control and Prevention’s Division of Vital Statistics.
Almost eight out of 10 long COVID-19 deaths were in White people, with Black people the second most-affected group at about 10 percent of the total.
For the latest headlines, follow our Google News channel online or via the app.
COVID-19 infection itself has killed more than 1 million people in the US, according to the CDC. Comprising immune, cardiac, and brain disturbances among others, long COVID-19 has no approved treatments and has affected as many as 23 million people in the US at varying levels of severity. While Harvard University researchers have estimated the disease may cost the $3.7 trillion, the CDC estimate is the first of deaths to date.
Numerous academic institutions and research organizations are studying the disease to find the best ways for prevention and treatment, as it still remains a mystery. While there is some evidence that long COVID-19 is less common in people who have been vaccinated, the condition can appear in people who have suffered mild or severe coronavirus infections.
Symptoms of long COVID-19 can include the moderate, such tiredness and brain fog, to the more serious, including respiratory and heart issues.
The vast majority of long COVID-19 deaths were among older people, with about three-quarters in people 65 and older. There is no diagnostic test for long COVID-19, as its cause isn’t well understood. The researchers looked at US death certificates for a variety of terms used to describe long COVID-19, such as “chronic COVID-19,” “long haul COVID-19,” “long hauler COVID-19,” “post-acute sequelae’ of COVID-19.
Pfizer’s Paxlovid antiviral medication lowers long-COVID risk: StudyPfizer Inc.’s blockbuster Paxlovid antiviral that lowers rates of illness and death in people infected with the coronavirus also cuts the risk of some ... Coronavirus
Long COVID’s link to suicide: Scientists warn of hidden crisis among sufferersScott Taylor never got to move on from COVID-19. The 56-year-old, who caught the disease in spring 2020, still had not recovered about 18 months later ... Coronavirus
Long COVID-19 patients traveling abroad for unproven ‘blood washing’ treatment: StudyInvestigators with the British Medical Journal have found that patients experiencing debilitating symptoms of so-called long COVID-19 are spending ... Coronavirus
Pfizer study shows COVID-19 booster can be given along with pneumonia shotPfizer said on Wednesday booster doses of its COVID-19 vaccine can be administered along with its pneumonia vaccine and produced strong safety and ... Coronavirus
COVID-19 pandemic no longer key priority for private healthcare companiesThe United Arab Emirates must “learn to live with COVID-19” and the pandemic response is no longer a key priority for businesses such as the country’s ... Coronavirus